February 22, 2023 at 12:16 pm

Benzo Withdrawal and Akathisia

It’s good to see the benzo podcast taking off. Listen and learn from experts by experience, some of whom have also been on MISSD’s Akathisia Stories podcast. Read the full article at https://markets.financialcontent.com/stocks/article/abnewswire-2023-2-17-the-benzodiazepine-podcast-is-about-fighting-gaslighting-of-protracted-benzo-withdrawal-sufferers. Listen at https://thebenzodiazepinepodcast.drleeds.com/

February 13, 2023 at 4:43 am

Hmm: What is Akathisia?

Harvard Health Publishing has really missed the boat when describing akathisia in this MSN Q&A. To call it a movement disorder and fail to mention the inner symptoms of akathisia–symptoms of inner restlessness and delirium that can cause violence and death is shockingly disappointing. See https://www.msn.com/en-ca/health/medical/what-is-akathisia-and-how-to-treat-it-harvard-health-publishing-weighs-in/ar-AA17oDhT?li=AAggV0S.

February 8, 2023 at 9:18 am

MISSD’s Podcast Shares the Real Experiences of Real People to Improve Healthcare Outcomes

Like many families who have lost loved ones to akathisia-induced death, Kristina explains how her teenage daughter’s akathisia symptoms were missed and misdiagnosed. Natalie, who died ten years ago this week, knew something was terribly wrong but didn’t know her Zoloft-induced symptoms had a medical name. Listen and learn at https://www.studiocchicago.com/akathisia-stories-blog/episode-3-kristina-gehrki.

February 3, 2023 at 1:34 pm

Healthcare Consumers Need Accurate Info

One out of seven people who try to stop depression pills will experience withdrawal problems, which can include akathisia. Informed consent can reduce medication-induced death.

“The principle of informed consent dictates that people must be told all this when first offered these drugs.” –John Reed, Professor of Clinical Psychology, London. See https://www.theguardian.com/science/2023/jan/31/informed-consent-for-antidepressants